Enlivex Therapeutics LtdNASDAQ:ENLV
- LAST PRICE0.9293
- TODAY'S CHANGE (%)0.0883 (10.4994%)
- Bid / Lots0.9399/ 3
- Ask / Lots0.9400/ 1
- Open / Previous Close0.8280 / 0.8410
- Day Range
- 52 Week Range
- Volume221,613
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ENLV |
|---|---|---|
| 09:32 ET | 4436 | 0.828 |
| 09:35 ET | 710 | 0.85 |
| 09:39 ET | 211 | 0.8695 |
| 09:50 ET | 100 | 0.889 |
| 09:51 ET | 300 | 0.87 |
| 09:55 ET | 363 | 0.88 |
| 09:57 ET | 7790 | 0.8801 |
| 10:00 ET | 2888 | 0.88 |
| 10:02 ET | 100 | 0.8732 |
| 10:04 ET | 4100 | 0.8645 |
| 10:06 ET | 300 | 0.864 |
| 10:08 ET | 150 | 0.8656 |
| 10:13 ET | 2100 | 0.86 |
| 10:15 ET | 3400 | 0.85 |
| 10:20 ET | 1098 | 0.852 |
| 10:24 ET | 2000 | 0.851999 |
| 10:26 ET | 858 | 0.854 |
| 10:27 ET | 200 | 0.8552 |
| 10:29 ET | 100 | 0.86 |
| 10:38 ET | 300 | 0.8553 |
| 10:40 ET | 100 | 0.855 |
| 10:42 ET | 545 | 0.8501 |
| 10:47 ET | 200 | 0.850201 |
| 10:56 ET | 3100 | 0.8501 |
| 11:00 ET | 100 | 0.86 |
| 11:02 ET | 200 | 0.8502 |
| 11:03 ET | 6630 | 0.83 |
| 11:16 ET | 1000 | 0.83 |
| 11:18 ET | 3500 | 0.83 |
| 11:20 ET | 300 | 0.845 |
| 11:21 ET | 404 | 0.8475 |
| 11:43 ET | 2248 | 0.86135 |
| 11:56 ET | 300 | 0.869 |
| 11:57 ET | 3488 | 0.8602 |
| 11:59 ET | 6200 | 0.86505 |
| 12:01 ET | 2400 | 0.875 |
| 12:03 ET | 7100 | 0.8849 |
| 12:06 ET | 2800 | 0.88505 |
| 12:08 ET | 1300 | 0.8802 |
| 12:12 ET | 3105 | 0.89 |
| 12:14 ET | 5800 | 0.89 |
| 12:17 ET | 10277 | 0.9 |
| 12:19 ET | 3241 | 0.8902 |
| 12:21 ET | 7825 | 0.8901 |
| 12:24 ET | 300 | 0.895 |
| 12:26 ET | 5914 | 0.8925 |
| 12:30 ET | 3200 | 0.895 |
| 12:32 ET | 4298 | 0.8925 |
| 12:42 ET | 200 | 0.89 |
| 12:44 ET | 11700 | 0.895 |
| 12:46 ET | 2884 | 0.895 |
| 12:48 ET | 500 | 0.8799 |
| 12:50 ET | 4266 | 0.875 |
| 12:55 ET | 100 | 0.875 |
| 01:09 ET | 104 | 0.88 |
| 01:18 ET | 550 | 0.8802 |
| 01:24 ET | 1000 | 0.8853 |
| 01:26 ET | 2300 | 0.8841 |
| 01:27 ET | 1300 | 0.89 |
| 01:29 ET | 100 | 0.889999 |
| 01:31 ET | 100 | 0.895 |
| 01:38 ET | 1000 | 0.89 |
| 01:44 ET | 400 | 0.8875 |
| 01:45 ET | 2850 | 0.89 |
| 01:47 ET | 400 | 0.8811 |
| 01:49 ET | 12230 | 0.89 |
| 01:51 ET | 1726 | 0.88 |
| 01:56 ET | 1120 | 0.8801 |
| 02:02 ET | 1500 | 0.896 |
| 02:12 ET | 7099 | 0.905 |
| 02:14 ET | 1492 | 0.8993 |
| 02:16 ET | 1800 | 0.9071 |
| 02:20 ET | 500 | 0.9016 |
| 02:21 ET | 515 | 0.9199 |
| 02:23 ET | 100 | 0.91075 |
| 02:36 ET | 2000 | 0.9094 |
| 02:41 ET | 200 | 0.919138 |
| 02:43 ET | 4063 | 0.9015 |
| 02:45 ET | 423 | 0.8966 |
| 02:48 ET | 105 | 0.9085 |
| 02:52 ET | 2287 | 0.908399 |
| 02:57 ET | 200 | 0.90255 |
| 03:01 ET | 1000 | 0.902549 |
| 03:03 ET | 267 | 0.8966 |
| 03:08 ET | 2200 | 0.8921 |
| 03:12 ET | 1900 | 0.89 |
| 03:14 ET | 400 | 0.89 |
| 03:15 ET | 300 | 0.9 |
| 03:17 ET | 6761 | 0.896 |
| 03:19 ET | 1500 | 0.89505 |
| 03:28 ET | 100 | 0.90005 |
| 03:30 ET | 100 | 0.91 |
| 03:37 ET | 3610 | 0.910099 |
| 03:39 ET | 700 | 0.9101 |
| 03:42 ET | 2800 | 0.9101 |
| 03:44 ET | 100 | 0.9101 |
| 03:50 ET | 100 | 0.9101 |
| 03:51 ET | 400 | 0.9164 |
| 03:53 ET | 736 | 0.9176 |
| 03:55 ET | 5200 | 0.91 |
| 04:00 ET | 4330 | 0.9293 |
Yesterday
DJ MicroStrategy Copycats Are Buying Bitcoin as Price Nears $100,000 -- Barrons.com, from 12:25PM ET on Friday Nov 22, 2024 by Dow Jones
12:25PM ET on Friday Nov 22, 2024 by Dow Jones
Nov 20, 2024
Enlivex Adopts Bitcoin Treasury Reserve Strategy, from 8:00AM ET on Wednesday Nov 20, 2024 by Dow Jones
8:00AM ET on Wednesday Nov 20, 2024 by Dow Jones
Nov 14, 2024
DJ Enlivex Therapeutics Is Maintained at Buy by D. Boral Capital, from 5:12PM ET on Thursday Nov 14, 2024 by Dow Jones
5:12PM ET on Thursday Nov 14, 2024 by Dow JonesEnlivex Announces the Dosing of the First Patient in a Phase I Clinical Trial Evaluating Allocetra in Patients with Psoriatic Arthritis, from 8:01AM ET on Thursday Nov 14, 2024 by Dow Jones
8:01AM ET on Thursday Nov 14, 2024 by Dow Jones
Nov 12, 2024
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Enlivex Therapeutics Ltd | 19.9M | -0.8x | --- |
Goldenwell Biotech Inc | 19.8M | -139.9x | --- |
Mira Pharmaceuticals Inc | 19.5M | -1.8x | --- |
CytoMed Therapeutics Ltd | 26.1M | -11.5x | --- |
NeuroBo Pharmaceuticals Inc | 20.4M | -0.5x | --- |
GlycoMimetics Inc | 20.4M | -0.5x | --- |
Company Information
Enlivex Therapeutics Ltd is an Israel-based clinical stage macrophage reprogramming immunotherapy company developing Allocetra, off-the-shelf cell therapy designed to reprogram macrophages into their homeostatic state. AllocetraTM is a therapy designed to reprogram macrophages into their homeostatic state. Diseases such as solid cancers, sepsis, COVID-19 and many others reprogram macrophages out of their homeostatic state. These non-homeostatic macrophages contribute significantly to the severity of the respective diseases. By restoring macrophage homeostasis, AllocetraTM has the potential to provide immunotherapeutic mechanism of action for life-threatening clinical indications that are defined as unmet medical needs, as a stand-alone therapy or in combination with therapeutic agents.
Contact Information
- Headquarters
- 14 Einstein St.NESS-ZIONA, Israel 7403618
- Phone
- ---
- Fax
- ---
Executives
- Chief Executive Officer
- Oren Hershkovitz
- Executive Chairman of the Board
- Shai Novik
- Founder, Chief Scientific Officer and Medical Officer
- Dror Mevorach
- Chief Financial Officer
- Shachar Shlosberger
- Director
- Baruch Halpert
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $19.9M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 21.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.99 |
EPS | $-1.19 |
Book Value | $1.62 |
P/E Ratio | -0.8x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
